{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:59:04Z","timestamp":1771934344435,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ygyno.2006.01.035","type":"journal-article","created":{"date-parts":[[2006,3,4]],"date-time":"2006-03-04T12:24:05Z","timestamp":1141475045000},"page":"447-452","source":"Crossref","is-referenced-by-count":28,"title":["Influence of interval between primary surgery and chemotherapy on short-term survival of patients with advanced ovarian, tubal or peritoneal cancer"],"prefix":"10.1016","volume":"102","author":[{"given":"Torbj\u00f8rn","family":"Paulsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janne","family":"K\u00e6rn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Kj\u00e6rheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tor","family":"Haldorsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claes","family":"Trop\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2006.01.035_bib1","first-page":"107","article-title":"Carcinoma of the ovary","volume":"6","author":"Heintz","year":"2001","journal-title":"J. Epidemiol. Biostat."},{"key":"10.1016\/j.ygyno.2006.01.035_bib2","unstructured":"Unpublished data from Cancer Registry of Norway. http:\/\/www.kreftregisteret.no\/frame.htm?forekomst_og_overlevelse_2001\/ovary\/incidence.htm. Cancer Registry of Norway; 2005."},{"key":"10.1016\/j.ygyno.2006.01.035_bib3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ijgo.2004.09.008","article-title":"Symptoms and referral of women with epithelial ovarian tumors","volume":"88","author":"Paulsen","year":"2005","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.ygyno.2006.01.035_bib4","unstructured":"Cancer in Norway 2002. Cancer Registry of Norway; 2005."},{"key":"10.1016\/j.ygyno.2006.01.035_bib5","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1067\/S0002-9378(03)00579-9","article-title":"Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades","volume":"189","author":"Barnholtz-Sloan","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib6","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/1097-0142(199007\/08)14:4<875::AID-CNCR2820140425>3.0.CO;2-6","article-title":"The development of spontaneous metastases after the removal of a \u201cprimary\u201d tumor: II. Standardization protocol of 5 animal tumors","volume":"14","author":"Ketcham","year":"1961","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.01.035_bib7","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/1097-0142(19940401)73:7<1870::AID-CNCR2820730716>3.0.CO;2-3","article-title":"Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma","volume":"73","author":"Kaern","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.01.035_bib8","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1097-0142(19980101)82:1<159::AID-CNCR20>3.0.CO;2-0","article-title":"The clinical predictivity of biomarkers of stage III\u2013IV epithelial ovarian cancer in a prospective randomized treatment protocol","volume":"82","author":"Silvestrini","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.01.035_bib9","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000010095","article-title":"Transforming growth factor-alpha levels in the serum and ascites of patients with advanced epithelial ovarian cancer","volume":"47","author":"Saltzman","year":"1999","journal-title":"Gynecol. Obstet. Invest."},{"key":"10.1016\/j.ygyno.2006.01.035_bib10","first-page":"2984","article-title":"Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer","volume":"7","author":"Reles","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ygyno.2006.01.035_bib11","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1054\/bjoc.2001.2101","article-title":"Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2","volume":"85","author":"Schuyer","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.ygyno.2006.01.035_bib12","first-page":"390","article-title":"Molecular mechanisms of apoptosis and chemosensitivity to platinum and paclitaxel in ovarian cancer: biological data and clinical implications","volume":"23","author":"Gadducci","year":"2002","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib13","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/gyno.2002.6620","article-title":"Cyclooxygenase-2 (COX-2), epidermal growth factor receptor (EGFR), and Her-2\/neu expression in ovarian cancer","volume":"85","author":"Ferrandina","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1097-0215(19960621)69:3<205::AID-IJC10>3.0.CO;2-6","article-title":"Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas","volume":"69","author":"Gasparini","year":"1996","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.ygyno.2006.01.035_bib15","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/mp.55.6.348","article-title":"Angiogenesis in epithelian ovarian cancer","volume":"55","author":"Bamberger","year":"2002","journal-title":"Mol. Pathol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib16","first-page":"1488","article-title":"Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases","volume":"43","author":"Fisher","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2006.01.035_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1200\/JCO.2005.03.065","article-title":"Relationship between time interval from primary surgery to the start of taxane-plus platinum-based chemotherapy and clinical outcome of patients with advanced epithelial ovarian cancer: results of a multicenter retrospective Italian study","volume":"23","author":"Gadducci","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1048-891X.2004.014509.x","article-title":"Prognostic importance of the time interval from surgery to chemotherapy in treatment of ovarian carcinoma","volume":"14","author":"Sorbe","year":"2004","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2006.01.035_bib19","unstructured":"Vergote I: http:\/\/www.eortc.be\/protoc\/default.htm: EORTC protocol 55981: a randomized trial of Paclitaxel\/Epirubicin\/Carboplatin Combination (TEC) versus Paclitaxel\/Carboplatin (TC) in the treatment of women with Advanced Ovarian Cancer. 1999."},{"key":"10.1016\/j.ygyno.2006.01.035_bib20","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0021-9681(60)90137-5","article-title":"Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide","volume":"11","author":"Zubrod","year":"1960","journal-title":"J. Chronic. Dis."},{"key":"10.1016\/j.ygyno.2006.01.035_bib21","doi-asserted-by":"crossref","unstructured":"Paulsen T, Kjaerheim K, Kaern J. et al. Improved short-term survival for advanced ovarian, tubar and peritoneal cancer patients operated at teaching hospitals. Int. J. Gynecol. Cancer 16 (Supplement 1) (in press).","DOI":"10.1136\/ijgc-00009577-200602001-00002"},{"key":"10.1016\/j.ygyno.2006.01.035_bib22","unstructured":"International Statistical Classification of Diseases. Injuries, and causes of death. Tenth Revision; 1992 [Geneva, WHO]."},{"key":"10.1016\/j.ygyno.2006.01.035_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0090-8258(86)90109-5","article-title":"Chemotherapy of advanced ovarian adenocarcinoma: a randomized comparison of combination versus sequential therapy using chlorambucil and cisplatin","volume":"23","year":"1986","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib24","first-page":"353","article-title":"Randomised comparison of cisplatin with cyclophosphamide\/cisplatin and with cyclophosphamide\/doxorubicin\/cisplatin in advanced ovarian cancer. Gruppo Interegionale Cooperativo Oncologico Ginecologia","volume":"2","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2006.01.035_bib25","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0090-8258(92)90272-K","article-title":"Long-term results of a randomized trial comparing cisplatin with cisplatin and cyclophosphamide with cisplatin, cyclophosphamide, and adriamycin in advanced ovarian cancer. GICOG (Gruppo Interregionale Cooperativo Oncologico Ginecologia), Italy","volume":"45","year":"1992","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib26","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1200\/JCO.1995.13.7.1589","article-title":"Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: a Gynecologic Oncology Group study","volume":"13","author":"McGuire","year":"1995","journal-title":"J. Clin. Oncol."},{"issue":"Suppl. 8","key":"10.1016\/j.ygyno.2006.01.035_bib27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/02841869609098528","article-title":"Doxorubicin-melphalan with and without cisplatin in advanced ovarian cancer-ten-year survival results from a prospective randomized study by the Swedish Cooperative Ovarian Cancer Study Group","volume":"35","author":"Trope","year":"1996","journal-title":"Acta Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib28","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1200\/JCO.1997.15.5.1938","article-title":"Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer","volume":"15","author":"Bolis","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1200\/JCO.1997.15.1.193","article-title":"Dose\u2013effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study","volume":"15","author":"Jakobsen","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib30","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/jnci\/92.9.699","article-title":"Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results","volume":"92","author":"Piccart","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2006.01.035_bib31","first-page":"S15","article-title":"Carboplatin\/paclitaxel versus cisplatin\/paclitaxel as first-line chemotherapy in advanced ovarian cancer: an interim analysis of a randomized phase III trial of the Arbeitsgemeinschaft Gynakologische Onkologie Ovarian Cancer Study Group","volume":"24","author":"du","year":"1997","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib32","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1200\/JCO.2000.18.17.3084","article-title":"Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer","volume":"18","author":"Neijt","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1525-1438.2003.13602.x","article-title":"Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel vs. cisplatin and paclitaxel (GOG 158) and an update on GOG0 182-ICON5","volume":"13","author":"Bookman","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.ygyno.2006.01.035_bib34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/gyno.1995.1027","article-title":"The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer","volume":"56","author":"Makar","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib35","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1002\/1097-0142(19940401)73:7<1870::AID-CNCR2820730716>3.0.CO;2-3","article-title":"Flow cytometric DNA ploidy and S-phase heterogeneity in advanced ovarian carcinoma","volume":"73","author":"Kaern","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2006.01.035_bib36","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.ygyno.2006.01.035_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0090-8258(90)90042-J","article-title":"Tumor reduction surgery and long-term survival in advanced ovarian cancer: a DACOVA study","volume":"38","author":"Bertelsen","year":"1990","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib38","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.1992.10.10.1561","article-title":"Ten-year outcome of patients with advanced epithelial ovarian carcinoma treated with cisplatin-based multimodality therapy","volume":"10","author":"Hoskins","year":"1992","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib39","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1006\/gyno.1995.1027","article-title":"The prognostic significance of residual disease, FIGO substage, tumor histology, and grade in patients with FIGO stage III ovarian cancer","volume":"56","author":"Makar","year":"1995","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib40","first-page":"1488","article-title":"Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases","volume":"43","author":"Fisher","year":"1983","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2006.01.035_bib41","first-page":"5533","article-title":"Timing of chemotherapy and surgery in a murine osteosarcoma model","volume":"48","author":"Bell","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.ygyno.2006.01.035_bib42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1006\/gyno.2002.6750","article-title":"Does the interval from primary surgery to chemotherapy influence progression-free survival in ovarian cancer?","volume":"86","author":"Flynn","year":"2002","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2006.01.035_bib43","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1343::AID-CNCR11>3.0.CO;2-#","article-title":"Effect of timing of postoperative chemotherapy on survival of dogs with osteosarcoma","volume":"79","author":"Berg","year":"1997","journal-title":"Cancer"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806000606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825806000606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T05:34:12Z","timestamp":1555479252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825806000606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0090825806000606"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2006.01.035","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}